Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA195558
National Institutes of Health
Grant: 5R01CA195558-03
HEXIM1 regulation of transcriptional networks critical for tumor suppression
National Institutes of Health
Grant: 1R43CA243833-01A1
Targeting GSK3 in AML
National Institutes of Health
Fields of Study
Keywords
Sustainable Development Goals